{
  "documentMetadata": {
    "title": "Complicated Urinary Tract Infection or Catheter-related Infection",
    "sourceFile": "UTI, Complicated or Catheter-related.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Complicated urinary tract infections (UTI): obstruction, reflux, azotemia, transplant.",
        "Foley catheter-related infection. For catheter management, see Comment below.",
        "Important to rule out obstruction."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Enterobacteriaceae",
        "Pseudomonas aeruginosa",
        "Enterococcus sp.",
        "Staphylococcus aureus (rare), Clin Infect Dis 42:46, 2006"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Empiric therapy:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "components": [
              {
                "drug": "Ciprofloxacin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "bid"
              },
              {
                "drug": "Ciprofloxacin extended release",
                "dose": "1000 mg",
                "route": "po",
                "frequency": "q24h",
                "connector": "or"
              },
              {
                "drug": "Ciprofloxacin",
                "dose": "400 mg",
                "route": "IV",
                "frequency": "q12h",
                "connector": "or"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Recommended",
            "components": [
              {
                "drug": "Levofloxacin",
                "dose": "750 mg",
                "route": "po/IV",
                "frequency": "q24h"
              }
            ]
          }
        },
        {
          "type": "paragraph",
          "text": "If patient with systemic illness or high risk for multi-drug resistant organisms, consider alternative regimens below for empiric therapy"
        },
        {
          "type": "paragraph",
          "text": "Specific therapy: based on bacterial speciation and drug susceptibility testing"
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Alternative",
        "condition": "if without signs or symptoms of systemic infection - fever, flank pain",
        "components": [
          {
            "drug": "Nitrofurantoin (Macrobid)",
            "dose": "100 mg",
            "route": "po",
            "frequency": "bid"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Alternative",
        "condition": "If local prevalence of resistance to TMP/SMX is < 20%",
        "components": [
          {
            "drug": "TMP-SMX-DS",
            "dose": "1 tab",
            "frequency": "bid"
          }
        ]
      }
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "If high risk for multi-drug resistant infection or systemic illness (see also Pyelonephritis):"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Ertapenem",
                "dose": "1gm",
                "route": "IV",
                "frequency": "q24h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Piperacillin-tazobactam",
                "dose": "4.5 gm",
                "route": "IV",
                "frequency": "q8h",
                "notes": "over 4 hr"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Cefepime",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q12h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Ceftazidime-avibactam",
                "dose": "2.5 gm",
                "route": "IV",
                "frequency": "q8h"
              }
            ]
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "strengthOfRecommendation": "Alternative",
            "components": [
              {
                "drug": "Plazomicin",
                "dose": "15 mg/kg",
                "route": "IV",
                "frequency": "q24h"
              }
            ]
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "For tiered approach to prevent catheter-associated UTI : Ann Int Med 2019;171:S30",
        "Duration of therapy: Recommended treatment in 7-14 days. If signs or symptoms of upper tract infection (fever, flank pain) treat for 14 days. Treat for 7 days for catheter-associated UTI if prompt resolution of symptoms, 10-14 days if delayed response; a 3-day course of therapy may be consider for women < 65 years of age (Clin Infect Dis 50:625, 2010)."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Replacing catheters: For patients with concomitant chronic necessary Foley catheter, results of a prospective hospital based study indicates no benefit to replacing the bladder catheter (J Am Geriatr Soc 2018; 66:1779).",
        "Special considerations:",
        "Cephalosporins and Ertapenem are not predictably active vs. Enterococcus sp. or P. aeruginosa.",
        "Ciprofloxacin is approved in children (age 1-17 yrs) as alternative but is not a first choice due to increased incidence of joint adverse effects.",
        "Pediatrics dose: Ciprofloxacin 6-10 mg/kg (400 mg max) IV q8h or 10-20 mg/kg (750 mg max) po q12h.",
        "See N Engl J Med 365:239, 2011 for recent review of diagnosis and treatment of pyelonephritis in children.",
        "Reference: Clin Infect Dis 50:625, 2010 for IDSA guidelines."
      ]
    }
  ]
}